Richard Harris

Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.

Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.

Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.

Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington (DC) Star.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.

A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.

Pages

Shots - Health News
2:04 pm
Fri April 25, 2014

Family Tree Of Pertussis Traced, Could Lead To Better Vaccine

False-color transmission electron micrograph of a field of whooping cough bacteria, Bordetella pertussis.
A. Barry Dowsett Science Source

Originally published on Mon April 28, 2014 5:51 am

Whooping cough was once one of the leading killers of babies around the world. Now that it's largely controlled with a vaccine, scientists have had a chance to figure out how the disease came into being in the first place.

That story is told in a study published online this week in the journal mBio. And it turns out that whooping cough arose quite late in human history.

Read more
Shots - Health News
12:14 pm
Thu April 17, 2014

First Embryonic Stem Cells Cloned From A Man's Skin

This mouse egg (top) is being injected with genetic material from an adult cell to ultimately create an embryo — and, eventually, embryonic stem cells. The process has been difficult to do with human cells.
James King-Holmes Science Source

Originally published on Wed April 30, 2014 10:20 am

Eighteen years ago, scientists in Scotland took the nuclear DNA from the cell of an adult sheep and put it into another sheep's egg cell that had been emptied of its own nucleus. The resulting egg was implanted in the womb of a third sheep, and the result was Dolly, the first clone of a mammal.

Dolly's birth set off a huge outpouring of ethical concern — along with hope that the same techniques, applied to human cells, could be used to treat myriad diseases.

Read more
Shots - Health News
2:06 pm
Fri April 11, 2014

Ebola Drug Could Be Ready For Human Testing Next Year

In this colored transmission electron micrograph, an infected cell (reddish brown) releases a single Ebola virus (the blue hook). As it exits, the virus takes along part of the host cell's membrane (pink, center), too. That deters the host's immune defenses from recognizing the virus as foreign.
London School of Hygiene & Tropical Medicine Science Source

Originally published on Fri April 11, 2014 6:13 pm

The Ebola outbreak in West Africa is terrifying because there's no drug to treat this often fatal disease. But the disease is so rare, there's no incentive for big pharmaceutical companies to develop a treatment.

Even so, some small companies, given government incentives, are stepping into that breach. The result: More than half a dozen ideas are being pursued actively.

Read more
Shots - Health News
1:44 am
Tue April 8, 2014

How Mouse Studies Lead Medical Research Down Dead Ends

I'm not trying to lead you astray. It's just that scientists are not skeptical enough about their mouse studies.
iStockphoto

Originally published on Wed April 9, 2014 6:59 am

Most experimental drugs fail before they make it through all the tests required to figure out if they actually work and if they're safe. But some drugs get fairly far down that road, at the cost of hundreds of millions of dollars, based on poorly conducted studies at the outset.

Medical researchers reviewing this sorry state of affairs say the drug-development process needs serious improvement.

Read more
Shots - Health News
11:22 am
Sun April 6, 2014

Simple Blood Test To Spot Early Lung Cancer Getting Closer

An artist's illustration shows lung cancer cells lurking among healthy air sacs.
David Mack Science Source

Originally published on Mon April 7, 2014 11:32 am

One of these days, there could well be a simple blood test that can help diagnose and track cancers. We aren't there yet, but a burst of research in this area shows we are getting a lot closer.

In the latest of these studies, scientists have used blood samples to identify people with lung cancer.

Read more

Pages